UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 248

Sortiert nach

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Gut, 2021-04, Vol.70 (4), p.725

2021

Link zum Volltext

Verfügbarkeit prüfen

Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis

Digestive diseases and sciences, 2023-04, Vol.68 (4), p.1118-1120

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

Inflammatory bowel diseases, 2022-10, Vol.28 (10), p.1497-1505

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Gastroenterology (New York, N.Y. 1943), 2022-01, Vol.162 (1), p.316-319.e5

2022

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients

Inflammatory bowel diseases, 2020-06, Vol.26 (7), p.1079-1086

2020

Link zum Volltext

Verfügbarkeit prüfen

Managing IBD in the COVID-19 era

Therapeutic Advances in Gastroenterology, 2023-01, Vol.16, p.17562848231176450-17562848231176450

2023

Link zum Volltext

Verfügbarkeit prüfen

Early Use of Biologics Reduces Healthcare Costs in Crohn’s Disease: Results from a United States Population-Based Cohort

Digestive diseases and sciences, 2024, Vol.69 (1), p.45-55

2024

Link zum Volltext

Verfügbarkeit prüfen

Editorial/introduction to special issue

Current research in pharmacology and drug discovery, 2022, Vol.3, p.100125-100125, Article 100125

2022

Link zum Volltext

Verfügbarkeit prüfen

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists

Gastroenterology (New York, N.Y. 1943), 2021-07, Vol.161 (1), p.47-65

2021

Link zum Volltext

Verfügbarkeit prüfen

What Should Gastroenterologists and Patients Know About COVID-19?

Clinical gastroenterology and hepatology, 2020-06, Vol.18 (7), p.1409-1411

2020

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD

BMJ open, 2021-11, Vol.11 (11), p.e049740-e049740

2021

Link zum Volltext

Verfügbarkeit prüfen

Unmet needs in inflammatory bowel disease

Current research in pharmacology and drug discovery, 2021-01, Vol.2, p.100070-100070, Article 100070

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2022-03, Vol.162 (3), p.987-988

2022

Link zum Volltext

Verfügbarkeit prüfen

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.481-491.e3

2020

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune and Chronic Inflammatory Disease Patients with COVID‐19

ACR open rheumatology, 2021-02, Vol.3 (2), p.111-115

2021

Link zum Volltext

Verfügbarkeit prüfen

Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?

Gastroenterology (New York, N.Y. 1943), 2022-04, Vol.162 (5), p.1452-1455

2022

Link zum Volltext

Verfügbarkeit prüfen

Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease

Alimentary pharmacology & therapeutics, 2020-05, Vol.51 (9), p.831-842

2020

Link zum Volltext

Verfügbarkeit prüfen

De-escalation of Therapy for Patients With Inflammatory Bowel Disease

Gastroenterology & hepatology, 2022-04, Vol.18 (4), p.213-215

Ungaro, Ryan C

2022

Link zum Volltext

Verfügbarkeit prüfen

Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid

Gastroenterology (New York, N.Y. 1943), 2023-01, Vol.164 (1), p.2-4

2023

Link zum Volltext

Verfügbarkeit prüfen

Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?

Current therapeutic research, 2021-01, Vol.95, p.100639-100639, Article 100639

2021

Link zum Volltext

Verfügbarkeit prüfen

High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2021-05, Vol.27 (6), p.791-796

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study

Therapeutic advances in gastroenterology, 2022, Vol.15, p.175628482211323-17562848221132363

2022

Link zum Volltext

Verfügbarkeit prüfen

Ultraprocessed Foods and the Risk of Inflammatory Bowel Disease: Is it Time to Modify Diet?

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (2), p.652-654

2022

Link zum Volltext

Verfügbarkeit prüfen

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data

Clinical gastroenterology and hepatology, 2023-12, Vol.21 (13), p.3433-3436.e1

2023

Link zum Volltext

Verfügbarkeit prüfen

Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients

Alimentary pharmacology & therapeutics, 2019-11, Vol.50 (10), p.1094-1099

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(246)
Mit Volltextzugriff
(231)

Publikationsform

Artikel
(245)
Buchkapitel
(3)

Sprache

Englisch
(248)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(112)
Science & Technology
(112)
Gastroenterology & Hepatology
(96)
Humans
(81)
Inflammatory Bowel Disease
(53)
Ulcerative Colitis
(35)
Crohn's Disease
(31)
Covid-19
(26)
Gastroenterology
(26)
Adult
(25)
Female
(25)
Male
(24)
Inflammatory Bowel Diseases - Drug Therapy
(21)
Sars-Cov-2
(19)
Patients
(18)
Retrospective Studies
(18)
Crohn Disease - Drug Therapy
(17)
Colitis, Ulcerative - Drug Therapy
(16)
Crohn’s Disease
(16)
Middle Aged
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients

Managing IBD in the COVID-19 era

Early Use of Biologics Reduces Healthcare Costs in Crohn’s Disease: Results from a United States Population-Based Cohort

Editorial/introduction to special issue

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists

What Should Gastroenterologists and Patients Know About COVID-19?

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD

Unmet needs in inflammatory bowel disease

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Autoimmune and Chronic Inflammatory Disease Patients with COVID‐19

Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?

Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease

De-escalation of Therapy for Patients With Inflammatory Bowel Disease

Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid

Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?

High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease

COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study

Ultraprocessed Foods and the Risk of Inflammatory Bowel Disease: Is it Time to Modify Diet?

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data

Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients

Suchergebnisse filtern